Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2363
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
||
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2221250
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
1405-36-3
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
ALTERNATIVE | |||
|
C73797
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
1091006
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
1987
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | RxNorm | ||
|
DBSALT000443
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
9H8D3J7V21
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
215-776-8
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
1405-37-4
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
m3029
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID30930861
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
SUB01029MIG
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
755904
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | |||
|
CAPREOMYCIN SULFATE
Created by
admin on Fri Dec 15 15:41:09 UTC 2023 , Edited by admin on Fri Dec 15 15:41:09 UTC 2023
|
PRIMARY | Description: A white or almost white powder. Solubility: Very soluble in water, practically insoluble in ethanol (~750 g/l) TS and in ether. Category: Antituberculosis drug. Storage: Capreomycin sulfate should be kept in a tightly closed container or, if sterile, in a hermetically closed container. Labelling: The label states, where applicable:(1) that the substance is free from bacterial endotoxins,(2) that the substance is sterile. Definition: Capreomycin sulfate is a mixture of the sulfates of antimicrobial polypeptides produced by the growth of Streptomyces capreolus. It contains not less than 70.0% of capreomycin, calculated with reference to the dried substance and taking into account the sum of capreomycin IA, IB, IIA and IIB. The contents of capreomycin IA and IB is not less than 90.0% of the sum of capreomycin IA, IB, IIA and IIB. |
All of the following components must be present:
ACTIVE MOIETY
SUBSTANCE RECORD